| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 36 | 2023 | 5061 | 4.430 |
Why?
|
| Carcinoma, Pancreatic Ductal | 22 | 2023 | 1724 | 4.310 |
Why?
|
| Interleukin-17 | 14 | 2023 | 250 | 3.950 |
Why?
|
| Gastrointestinal Microbiome | 6 | 2023 | 907 | 1.440 |
Why?
|
| Microbiota | 4 | 2021 | 547 | 1.300 |
Why?
|
| Extracellular Traps | 3 | 2023 | 25 | 1.170 |
Why?
|
| Bacteria | 4 | 2023 | 611 | 0.960 |
Why?
|
| Pancreas, Exocrine | 1 | 2023 | 22 | 0.890 |
Why?
|
| Tumor Microenvironment | 7 | 2024 | 2864 | 0.810 |
Why?
|
| Vitamin D | 1 | 2023 | 261 | 0.800 |
Why?
|
| Deoxycytidine | 6 | 2021 | 1353 | 0.780 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 162 | 0.770 |
Why?
|
| Adenocarcinoma | 5 | 2023 | 7789 | 0.740 |
Why?
|
| Albumins | 3 | 2020 | 258 | 0.740 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2019 | 56 | 0.680 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2021 | 1331 | 0.670 |
Why?
|
| Adenocarcinoma in Situ | 1 | 2018 | 31 | 0.630 |
Why?
|
| Chemokines, CXC | 4 | 2006 | 117 | 0.610 |
Why?
|
| Bacterial Infections | 1 | 2021 | 479 | 0.600 |
Why?
|
| Pneumonia, Pneumocystis | 4 | 2006 | 68 | 0.600 |
Why?
|
| Mice | 35 | 2023 | 34495 | 0.580 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2018 | 221 | 0.560 |
Why?
|
| Colorectal Neoplasms | 5 | 2023 | 3578 | 0.550 |
Why?
|
| Interleukins | 3 | 2015 | 325 | 0.550 |
Why?
|
| Germ-Line Mutation | 4 | 2022 | 1046 | 0.550 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 423 | 0.540 |
Why?
|
| Animals | 40 | 2023 | 59536 | 0.530 |
Why?
|
| Fluorouracil | 3 | 2021 | 1944 | 0.530 |
Why?
|
| Neoplasms | 6 | 2024 | 15193 | 0.520 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 651 | 0.510 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 715 | 0.500 |
Why?
|
| Paclitaxel | 3 | 2020 | 1996 | 0.500 |
Why?
|
| Hematopoietic System | 1 | 2014 | 26 | 0.500 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 1258 | 0.500 |
Why?
|
| Deoxycytidine Kinase | 1 | 2014 | 27 | 0.490 |
Why?
|
| Receptors, Interleukin-17 | 5 | 2023 | 20 | 0.490 |
Why?
|
| ELAV Proteins | 1 | 2014 | 18 | 0.490 |
Why?
|
| Humans | 60 | 2024 | 261506 | 0.490 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 5539 | 0.480 |
Why?
|
| Interleukin-6 | 1 | 2018 | 1038 | 0.460 |
Why?
|
| Receptors, Interleukin | 4 | 2018 | 97 | 0.450 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2015 | 272 | 0.410 |
Why?
|
| Epithelial Cells | 3 | 2018 | 1818 | 0.400 |
Why?
|
| Precancerous Conditions | 4 | 2022 | 1058 | 0.380 |
Why?
|
| Pyruvic Acid | 3 | 2022 | 133 | 0.380 |
Why?
|
| Biomarkers | 3 | 2021 | 5047 | 0.380 |
Why?
|
| Neoplastic Stem Cells | 2 | 2018 | 1443 | 0.370 |
Why?
|
| Immunotherapy | 7 | 2024 | 3341 | 0.360 |
Why?
|
| Germ Cells | 2 | 2022 | 335 | 0.360 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2023 | 490 | 0.350 |
Why?
|
| Neutrophils | 4 | 2022 | 835 | 0.350 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2017 | 673 | 0.340 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 114 | 0.340 |
Why?
|
| BRCA1 Protein | 3 | 2021 | 493 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2992 | 0.330 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 1390 | 0.320 |
Why?
|
| Pancreas | 3 | 2019 | 718 | 0.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2022 | 5319 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2019 | 2359 | 0.320 |
Why?
|
| Interferon-gamma | 4 | 2006 | 1144 | 0.320 |
Why?
|
| BRCA2 Protein | 2 | 2021 | 358 | 0.320 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 1299 | 0.310 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2023 | 469 | 0.300 |
Why?
|
| Cystic Fibrosis | 3 | 2008 | 264 | 0.290 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 15862 | 0.290 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5178 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 6942 | 0.280 |
Why?
|
| Pneumocystis | 1 | 2005 | 13 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2005 | 650 | 0.270 |
Why?
|
| Lung Neoplasms | 4 | 2022 | 11538 | 0.260 |
Why?
|
| Cell Line, Tumor | 8 | 2022 | 14551 | 0.260 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2009 | 582 | 0.260 |
Why?
|
| Neuroendocrine Tumors | 2 | 2022 | 634 | 0.260 |
Why?
|
| Bacteroides fragilis | 2 | 2018 | 7 | 0.250 |
Why?
|
| Antineoplastic Agents | 4 | 2022 | 14289 | 0.250 |
Why?
|
| Carbon Isotopes | 3 | 2022 | 333 | 0.250 |
Why?
|
| Betacoronavirus | 2 | 2020 | 527 | 0.250 |
Why?
|
| Bronchi | 2 | 2007 | 326 | 0.250 |
Why?
|
| Inflammation | 7 | 2018 | 2522 | 0.240 |
Why?
|
| Carcinogenesis | 3 | 2020 | 1026 | 0.240 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 408 | 0.240 |
Why?
|
| Pneumocystis carinii | 1 | 2004 | 20 | 0.240 |
Why?
|
| Carcinoma in Situ | 2 | 2020 | 487 | 0.240 |
Why?
|
| Intestinal Polyposis | 1 | 2023 | 30 | 0.230 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2006 | 1016 | 0.230 |
Why?
|
| Genetic Testing | 2 | 2022 | 1589 | 0.230 |
Why?
|
| Staining and Labeling | 2 | 2022 | 429 | 0.230 |
Why?
|
| Sexism | 1 | 2023 | 51 | 0.230 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3230 | 0.220 |
Why?
|
| Adenosine Deaminase | 1 | 2023 | 94 | 0.220 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2022 | 20 | 0.220 |
Why?
|
| Pancreatitis | 2 | 2023 | 267 | 0.220 |
Why?
|
| Cell Proliferation | 2 | 2015 | 7226 | 0.220 |
Why?
|
| Adenoma | 2 | 2018 | 716 | 0.210 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2005 | 749 | 0.210 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2023 | 167 | 0.210 |
Why?
|
| Antibodies | 3 | 2022 | 838 | 0.210 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2022 | 100 | 0.210 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 675 | 0.200 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2022 | 1062 | 0.200 |
Why?
|
| Interferons | 1 | 2023 | 291 | 0.200 |
Why?
|
| Paraffin Embedding | 1 | 2022 | 226 | 0.200 |
Why?
|
| Male | 22 | 2021 | 123000 | 0.200 |
Why?
|
| Epidemiologic Methods | 1 | 2021 | 254 | 0.190 |
Why?
|
| Lipocalin-2 | 1 | 2021 | 65 | 0.190 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 4298 | 0.190 |
Why?
|
| Endogenous Retroviruses | 1 | 2020 | 41 | 0.190 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2020 | 624 | 0.190 |
Why?
|
| Colon | 2 | 2018 | 670 | 0.190 |
Why?
|
| Mice, Knockout | 4 | 2023 | 5710 | 0.190 |
Why?
|
| Polyamines | 1 | 2020 | 75 | 0.180 |
Why?
|
| Fungi | 1 | 2021 | 145 | 0.180 |
Why?
|
| Signal Transduction | 5 | 2023 | 11965 | 0.180 |
Why?
|
| Pancreatectomy | 2 | 2022 | 652 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 7702 | 0.180 |
Why?
|
| Mutation Rate | 1 | 2020 | 223 | 0.180 |
Why?
|
| Female | 18 | 2023 | 141928 | 0.180 |
Why?
|
| Tumor Escape | 1 | 2021 | 251 | 0.170 |
Why?
|
| Feces | 2 | 2020 | 770 | 0.170 |
Why?
|
| Metalloendopeptidases | 2 | 2018 | 170 | 0.170 |
Why?
|
| Dysbiosis | 1 | 2020 | 134 | 0.170 |
Why?
|
| Immunization, Passive | 1 | 2020 | 172 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 254 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 5437 | 0.170 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 149 | 0.160 |
Why?
|
| Octamer Transcription Factors | 1 | 2018 | 19 | 0.160 |
Why?
|
| Immunoconjugates | 1 | 2022 | 279 | 0.160 |
Why?
|
| Cancer Vaccines | 2 | 2023 | 697 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 4654 | 0.160 |
Why?
|
| Bacterial Toxins | 2 | 2018 | 228 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2022 | 649 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2019 | 9244 | 0.160 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 91 | 0.160 |
Why?
|
| Medical History Taking | 1 | 2018 | 173 | 0.160 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2018 | 103 | 0.160 |
Why?
|
| Aged | 9 | 2021 | 70117 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 4 | 2006 | 2314 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 1586 | 0.150 |
Why?
|
| Anilides | 1 | 2019 | 268 | 0.150 |
Why?
|
| B7-1 Antigen | 1 | 2017 | 88 | 0.150 |
Why?
|
| Transcription Factor RelA | 1 | 2018 | 184 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 4143 | 0.150 |
Why?
|
| Pancreatitis, Chronic | 1 | 2018 | 116 | 0.150 |
Why?
|
| ras Proteins | 2 | 2019 | 770 | 0.150 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 1688 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2021 | 677 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2330 | 0.150 |
Why?
|
| Middle Aged | 10 | 2021 | 86204 | 0.150 |
Why?
|
| DNA Mismatch Repair | 1 | 2018 | 268 | 0.140 |
Why?
|
| Biomarkers, Tumor | 3 | 2020 | 10331 | 0.140 |
Why?
|
| Genes, p53 | 1 | 2021 | 1090 | 0.140 |
Why?
|
| Intestinal Mucosa | 3 | 2023 | 1081 | 0.140 |
Why?
|
| Age of Onset | 1 | 2018 | 827 | 0.140 |
Why?
|
| Genetic Counseling | 1 | 2018 | 380 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2006 | 1033 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2018 | 209 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 651 | 0.140 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 7222 | 0.140 |
Why?
|
| Mice, SCID | 5 | 2006 | 1869 | 0.130 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 29902 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 1265 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2022 | 3033 | 0.130 |
Why?
|
| Receptors, CXCR3 | 2 | 2006 | 36 | 0.130 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 2283 | 0.130 |
Why?
|
| Lung | 6 | 2019 | 3151 | 0.130 |
Why?
|
| Chemokine CXCL10 | 2 | 2006 | 105 | 0.130 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 1506 | 0.130 |
Why?
|
| Acinar Cells | 1 | 2014 | 53 | 0.120 |
Why?
|
| Breast | 1 | 2021 | 1344 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2020 | 717 | 0.120 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2014 | 17 | 0.120 |
Why?
|
| Lymphocyte Depletion | 2 | 2006 | 264 | 0.120 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1341 | 0.120 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1048 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 541 | 0.120 |
Why?
|
| Pandemics | 2 | 2020 | 1559 | 0.120 |
Why?
|
| Physicians | 1 | 2022 | 882 | 0.120 |
Why?
|
| Ribonuclease III | 1 | 2014 | 182 | 0.120 |
Why?
|
| Risk Factors | 3 | 2021 | 17523 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 166 | 0.120 |
Why?
|
| CTLA-4 Antigen | 1 | 2017 | 657 | 0.110 |
Why?
|
| Prognosis | 5 | 2022 | 21713 | 0.110 |
Why?
|
| Adult | 7 | 2021 | 77950 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2022 | 37905 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 255 | 0.110 |
Why?
|
| Chemoprevention | 1 | 2014 | 241 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2014 | 162 | 0.110 |
Why?
|
| Pyridines | 1 | 2019 | 1244 | 0.110 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2018 | 56 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2014 | 652 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1021 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 734 | 0.100 |
Why?
|
| Adenoviridae | 3 | 2006 | 1459 | 0.100 |
Why?
|
| Phenotype | 1 | 2023 | 6295 | 0.100 |
Why?
|
| Aspirin | 1 | 2014 | 455 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2018 | 2218 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 521 | 0.100 |
Why?
|
| Disease Progression | 2 | 2021 | 6682 | 0.090 |
Why?
|
| Organoids | 2 | 2023 | 287 | 0.090 |
Why?
|
| Prevalence | 1 | 2018 | 3260 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 5159 | 0.090 |
Why?
|
| Cell Polarity | 2 | 2014 | 208 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 973 | 0.090 |
Why?
|
| Spleen | 3 | 2008 | 676 | 0.090 |
Why?
|
| Chemokines | 2 | 2008 | 314 | 0.090 |
Why?
|
| Interleukin-23 | 2 | 2008 | 29 | 0.090 |
Why?
|
| Survival Rate | 2 | 2019 | 12221 | 0.090 |
Why?
|
| Age Factors | 1 | 2018 | 5377 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2008 | 5637 | 0.080 |
Why?
|
| Chemokine CXCL1 | 2 | 2005 | 60 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2021 | 6869 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2021 | 32848 | 0.080 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2020 | 299 | 0.080 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 212 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2014 | 1620 | 0.080 |
Why?
|
| Time Factors | 2 | 2021 | 12926 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 470 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2008 | 108 | 0.080 |
Why?
|
| Klebsiella Infections | 1 | 2008 | 64 | 0.080 |
Why?
|
| Klebsiella pneumoniae | 1 | 2008 | 98 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2018 | 9180 | 0.070 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2005 | 4 | 0.070 |
Why?
|
| Macrophages, Alveolar | 1 | 2005 | 67 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 8873 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 2594 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 66 | 0.070 |
Why?
|
| Leukocytes | 1 | 2008 | 422 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 26 | 0.070 |
Why?
|
| Gene Expression | 1 | 2014 | 3570 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2005 | 77 | 0.070 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 260 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 4988 | 0.060 |
Why?
|
| Vaccines, DNA | 1 | 2005 | 105 | 0.060 |
Why?
|
| Chemoradiotherapy | 1 | 2014 | 1946 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 992 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 203 | 0.060 |
Why?
|
| Chemokine CXCL9 | 1 | 2004 | 22 | 0.060 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2004 | 84 | 0.060 |
Why?
|
| Opportunistic Infections | 1 | 2005 | 223 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6207 | 0.060 |
Why?
|
| Taurine | 1 | 2023 | 23 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2005 | 156 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3981 | 0.060 |
Why?
|
| Ligands | 1 | 2006 | 995 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2004 | 109 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2019 | 1442 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 716 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 14889 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 363 | 0.060 |
Why?
|
| 5'-Nucleotidase | 1 | 2023 | 61 | 0.060 |
Why?
|
| Epithelium | 1 | 2005 | 720 | 0.060 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2017 | 105 | 0.050 |
Why?
|
| Serotonin | 1 | 2023 | 264 | 0.050 |
Why?
|
| Kinetics | 1 | 2005 | 2049 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 10001 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 850 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 4367 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2021 | 1113 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2022 | 486 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2022 | 185 | 0.050 |
Why?
|
| Adenosine | 1 | 2023 | 289 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 156 | 0.050 |
Why?
|
| X-linked Nuclear Protein | 1 | 2020 | 56 | 0.050 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 1 | 2019 | 27 | 0.050 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 122 | 0.050 |
Why?
|
| Cell Plasticity | 1 | 2020 | 66 | 0.040 |
Why?
|
| Pancreatic Ducts | 1 | 2020 | 122 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2022 | 329 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2019 | 43 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1538 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2021 | 4307 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 2927 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 227 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 264 | 0.040 |
Why?
|
| Thyroid Hormones | 1 | 2019 | 111 | 0.040 |
Why?
|
| Intestines | 1 | 2023 | 686 | 0.040 |
Why?
|
| CA-19-9 Antigen | 1 | 2019 | 144 | 0.040 |
Why?
|
| Probiotics | 1 | 2021 | 228 | 0.040 |
Why?
|
| Cell Movement | 1 | 2006 | 2466 | 0.040 |
Why?
|
| Leucovorin | 1 | 2019 | 332 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 1547 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2004 | 1694 | 0.040 |
Why?
|
| Neutralization Tests | 2 | 2009 | 299 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2020 | 613 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2018 | 159 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2018 | 98 | 0.040 |
Why?
|
| Melanoma | 1 | 2015 | 5317 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 446 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 1234 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 925 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2018 | 1121 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2019 | 305 | 0.040 |
Why?
|
| Mutation | 3 | 2022 | 15179 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 4938 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 376 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2022 | 1681 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 15694 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 677 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2018 | 269 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 519 | 0.030 |
Why?
|
| Homeostasis | 1 | 2021 | 950 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 1391 | 0.030 |
Why?
|
| Exercise | 1 | 2023 | 1183 | 0.030 |
Why?
|
| Cytokines | 2 | 2020 | 2809 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 1546 | 0.030 |
Why?
|
| Telemedicine | 1 | 2021 | 471 | 0.030 |
Why?
|
| Colitis | 2 | 2009 | 340 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2022 | 1154 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2018 | 1764 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1440 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 430 | 0.030 |
Why?
|
| Transcriptome | 1 | 2022 | 1859 | 0.030 |
Why?
|
| Farnesol | 1 | 2012 | 15 | 0.030 |
Why?
|
| Salicylates | 1 | 2012 | 59 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 2483 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 4971 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 5114 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2019 | 2022 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 5112 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 6150 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 6086 | 0.020 |
Why?
|
| Bacteroides Infections | 1 | 2009 | 10 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 2008 | 3869 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 639 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 4053 | 0.020 |
Why?
|
| Enterotoxins | 1 | 2009 | 112 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5687 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 3343 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2019 | 2819 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 4975 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 634 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 3552 | 0.020 |
Why?
|
| Joints | 1 | 2007 | 47 | 0.020 |
Why?
|
| Bronchiectasis | 1 | 2007 | 26 | 0.020 |
Why?
|
| Cartilage | 1 | 2007 | 128 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 206 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2006 | 170 | 0.020 |
Why?
|
| Chemokine CXCL5 | 1 | 2005 | 13 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1987 | 0.020 |
Why?
|
| Proprotein Convertases | 1 | 2005 | 25 | 0.020 |
Why?
|
| Haplorhini | 1 | 2005 | 130 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2005 | 91 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2006 | 257 | 0.020 |
Why?
|
| Immune System | 1 | 2007 | 279 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2005 | 138 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2005 | 115 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2006 | 250 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 1008 | 0.020 |
Why?
|
| Antigens | 1 | 2005 | 292 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 2054 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 591 | 0.020 |
Why?
|
| Plasmids | 1 | 2005 | 837 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 7548 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 3821 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 1082 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 769 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 2488 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 21445 | 0.010 |
Why?
|
| Antigens, CD19 | 1 | 2005 | 577 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 1489 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 1519 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 445 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1487 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 778 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 1021 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 1479 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 2450 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 31252 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 1013 | 0.010 |
Why?
|
| Proteomics | 1 | 2005 | 1380 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 3254 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 2693 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2008 | 2967 | 0.010 |
Why?
|